ATE271860T1 - Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit - Google Patents

Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Info

Publication number
ATE271860T1
ATE271860T1 AT00964272T AT00964272T ATE271860T1 AT E271860 T1 ATE271860 T1 AT E271860T1 AT 00964272 T AT00964272 T AT 00964272T AT 00964272 T AT00964272 T AT 00964272T AT E271860 T1 ATE271860 T1 AT E271860T1
Authority
AT
Austria
Prior art keywords
endometriosis
infertility
fertility
treatment
increase
Prior art date
Application number
AT00964272T
Other languages
German (de)
English (en)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of ATE271860T1 publication Critical patent/ATE271860T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT00964272T 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit ATE271860T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25
PCT/EP2000/009708 WO2001024788A2 (en) 1999-10-05 2000-10-04 Treating endometriosis or infertility, or improving fertility

Publications (1)

Publication Number Publication Date
ATE271860T1 true ATE271860T1 (de) 2004-08-15

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964272T ATE271860T1 (de) 1999-10-05 2000-10-04 Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit

Country Status (28)

Country Link
EP (1) EP1220667B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003510354A (cg-RX-API-DMAC7.html)
KR (1) KR100738724B1 (cg-RX-API-DMAC7.html)
CN (1) CN1218694C (cg-RX-API-DMAC7.html)
AR (1) AR028487A1 (cg-RX-API-DMAC7.html)
AT (1) ATE271860T1 (cg-RX-API-DMAC7.html)
AU (1) AU780736B2 (cg-RX-API-DMAC7.html)
BR (1) BR0014548A (cg-RX-API-DMAC7.html)
CA (1) CA2385974C (cg-RX-API-DMAC7.html)
CO (1) CO5251423A1 (cg-RX-API-DMAC7.html)
DE (1) DE60012554T2 (cg-RX-API-DMAC7.html)
DK (1) DK1220667T3 (cg-RX-API-DMAC7.html)
ES (1) ES2223581T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20043313B (cg-RX-API-DMAC7.html)
HK (1) HK1044120B (cg-RX-API-DMAC7.html)
HU (1) HU225990B1 (cg-RX-API-DMAC7.html)
IL (2) IL148784A0 (cg-RX-API-DMAC7.html)
MA (1) MA25501A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02003453A (cg-RX-API-DMAC7.html)
MY (1) MY129518A (cg-RX-API-DMAC7.html)
NO (1) NO329663B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ518429A (cg-RX-API-DMAC7.html)
PE (1) PE20010742A1 (cg-RX-API-DMAC7.html)
PT (1) PT1220667E (cg-RX-API-DMAC7.html)
TR (1) TR200200899T2 (cg-RX-API-DMAC7.html)
TW (1) TWI280877B (cg-RX-API-DMAC7.html)
UA (1) UA74168C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001024788A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
MX2012010327A (es) * 2010-03-22 2012-11-16 Repros Therapeutics Inc Composiciones y metodos para la administracion no toxica de antiprogestinas.
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
CA2872644A1 (en) 2012-05-31 2013-12-05 Allergan Pharmaceuticals International Limited Formulations and methods for vaginal delivery of antiprogestins
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions
CN116172995A (zh) * 2023-01-17 2023-05-30 浙江大学医学院附属妇产科医院 一种沙丁胺醇在制备治疗子宫内膜异位症的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
KR100738724B1 (ko) 2007-07-12
HU225990B1 (en) 2008-02-28
IL148784A0 (en) 2002-09-12
EP1220667B1 (en) 2004-07-28
CA2385974C (en) 2010-01-26
NO20021591D0 (no) 2002-04-04
CN1377264A (zh) 2002-10-30
HK1044120A1 (en) 2002-10-11
TR200200899T2 (tr) 2002-07-22
UA74168C2 (uk) 2005-11-15
MXPA02003453A (es) 2002-08-20
MY129518A (en) 2007-04-30
NZ518429A (en) 2004-02-27
WO2001024788A2 (en) 2001-04-12
NO20021591L (no) 2002-05-28
KR20020062285A (ko) 2002-07-25
CO5251423A1 (es) 2003-02-28
HUP0203050A3 (en) 2006-02-28
MA25501A1 (fr) 2002-07-01
AR028487A1 (es) 2003-05-14
ES2223581T3 (es) 2005-03-01
WO2001024788A3 (en) 2001-12-06
DE60012554D1 (de) 2004-09-02
HUP0203050A2 (hu) 2003-02-28
IL148784A (en) 2006-12-31
JP2010018639A (ja) 2010-01-28
DK1220667T3 (da) 2004-12-06
NO329663B1 (no) 2010-11-29
AU780736B2 (en) 2005-04-14
AU7525000A (en) 2001-05-10
CA2385974A1 (en) 2001-04-12
PE20010742A1 (es) 2001-07-19
CN1218694C (zh) 2005-09-14
EP1220667A2 (en) 2002-07-10
DE60012554T2 (de) 2005-11-24
GEP20043313B (en) 2004-03-10
PT1220667E (pt) 2004-11-30
HK1044120B (en) 2004-12-17
JP2003510354A (ja) 2003-03-18
TWI280877B (en) 2007-05-11
BR0014548A (pt) 2002-06-04

Similar Documents

Publication Publication Date Title
ATE250575T1 (de) Ep4 rezeptor selektive agonisten zur behandlung der osteoporose
DE69931975D1 (de) FSH Mimetika zur Behandlung von Infertilität
DE69941280D1 (de) Vorrichtung zur Behandlung von Stenosen an Verzweigungen
DE60022692D1 (de) (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69716525D1 (de) Handgelenkstütze zur Behandlung des Karpaltunnelsyndroms
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
DE69928542D1 (de) 5ht2-agoniste zur behandlung des glaukoms
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
DE60032905D1 (de) Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
DE69819515D1 (de) Hydroxy-prostaglandinderivaten zur behandlung der erektilen dysfunktion
NO995823D0 (no) Terapeutisk middel for ereksjonsdysfunksjon
DE60012554D1 (de) Beta-agonisten zur behandlung der endometriose bzw. unfruchtbarkeit oder steigerung der fruchtbarkeit
HUP0200912A3 (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual disfunction
DE69941821D1 (de) Fluorenthaltende zusammensetzung zur behandlung von oberflächen
DE60031790D1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE69937624D1 (de) Verfahren zur Behandlung von Metalloberflächen
DE69836464D1 (de) Orale Zusammensetzung für die Behandlung von übelriechendem Atem
DE59707096D1 (de) Haarbehandlungsmittel zur Festigung der Haare
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
EP1231840A4 (en) ANTI-ANGIOGENIC CELLULAR AGENT FOR CANCER TREATMENT
DE59904802D1 (de) Vorrichtung zur Behandlung von Biomolekülen
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220667

Country of ref document: EP